The size and share of the market is categorized based on Type (Bioinformatics Software, Bioinformatics Services) and Application (Research and Academic Institutes, Biopharmaceutical Companies, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The size and share of the market is categorized based on Type (Hardware, Software) and Application (Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Global Bioinformatics Market Size By Technology (Knowledge Management Tools, Bioinformatics Platforms), By Application (Metabolomics, Molecular Phylogenetics), By Geographic Scope And Forecast

United States bioinformatics market size is projected to exhibit a growth rate (CAGR) of 14.50% during 2024-2032. The recent advancements in sequencing technologies, shifting trend towards personalized medicine in healthcare, increasing establishment of biobanks, rising government fundings and initiatives, and the integration of artificial intelligence (AI) represent some of the key factors driving the market.

Report Attribute	Key Statistics
Base Year	2023
Forecast Years	2024-2032
Historical Years	2018-2023
Market Growth Rate (2024-2032)	14.50%

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product and service, application, and end use sector.

Explore the progression of average salaries for graduates in Biotechnology Bioinformatics from 2020 to 2023 through this detailed chart. It compares these figures against the national average for all graduates, offering a comprehensive look at the earning potential of Biotechnology Bioinformatics relative to other fields. This data is essential for students assessing the return on investment of their education in Biotechnology Bioinformatics, providing a clear picture of financial prospects post-graduation.

The global bioinformatics market size reached USD 13.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.4 Billion by 2033, exhibiting a growth rate (CAGR) of 11.69% during 2025-2033. Rapid technological advancements, increasing genomic sequencing, surging demand for personalized medicine, data analytics growth, investment in research and development (R&D), expanding biological databases, and the rising focus on preventive care are some of the factors fostering the market growth.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 13.9 Billion
Market Forecast in 2033	USD 39.4 Billion
Market Growth Rate 2025-2033	11.69%

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the product and service, application, and end-use sector.

List of Jobs Posts across several job application sites.

Computational Biological Market size was valued at USD 8.39 Billion in 2024 and is projected to reach USD 33.11 Billion by 2031, growing at a CAGR of 20.64% from 2024 to 2031.

Global Computational Biology Market Drivers

Growing Need for Personalized Medicine: The study of genetic data is making personalized medicine possible thanks to developments in computational biology. As more healthcare professionals want to give individualized therapies based on patient profiles, this is a major growth driver.

Growth in Drug Discovery and Development: By employing bioinformatics tools to model drug interactions and predict outcomes, computational biology plays a critical role in speeding up the drug discovery process and lowering costs and time associated with pharmaceutical R&D.

Increased Investment in Proteomics and Genomics: To gain a deeper understanding of disease mechanisms and possible treatments, governments, academic institutions, and commercial businesses are investing more money in proteomics and genomics. This is achieved by utilizing computational tools for large-scale biological data analysis.

The size and share of the market is categorized based on Type (Tools, Reagents) and Application (Proteomics, Cell biology research, Epigenetics, Metabolomics, Bioinformatics, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Explore the progression of average salaries for graduates in Bioinformatics And Comp Biology from 2020 to 2023 through this detailed chart. It compares these figures against the national average for all graduates, offering a comprehensive look at the earning potential of Bioinformatics And Comp Biology relative to other fields. This data is essential for students assessing the return on investment of their education in Bioinformatics And Comp Biology, providing a clear picture of financial prospects post-graduation.

The biomarker discovery outsourcing service market is estimated to be valued at US$ 13.3 billion in 2024. The biomarker discovery outsourcing service market is predicted to rise at a CAGR of 12.2% from 2024 to 2034. The global biomarker discovery outsourcing service market is anticipated to reach US$ 41.4 billion by 2034.

Attributes	Key Insights
Estimated Market Size in 2024	US$ 13.3 billion
Projected Market Value in 2034	US$ 41.4 billion
Value-based CAGR from 2024 to 2034	12.2%

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

Historical CAGR from 2019 to 2023	15.6%
Forecast CAGR from 2024 to 2034	12.2%

Country-wise Analysis

Countries	Forecast CAGRs from 2024 to 2034
The United States	12.4%
The United Kingdom	13.3%
China	12.9%
Japan	13.9%
South Korea	14.0%

Category wise Insights

Category	CAGR from 2024 to 2034
Surrogate End-point	12.0%
Genomic Biomarker Services	11.8%

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 31.1 billion
Projected Market Valuation in 2034	US$ 41.4 billion
Value-based CAGR 2024 to 2034	12.2%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ billion
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Type Service Therapeutic Area End User Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Bio-Rad Laboratories, Inc. Parexel International (MA) Corporation Svar Life Science Sino Biological Inc. ICON plc. Integrated DNA Technologies Inc. Almac Group Limited REPROCELL Inc. Frontage Labs Biomcare ApS Crown Bioscience

Explore the progression of average salaries for graduates in Genetics, Bioinformatics & Computational Biology from 2020 to 2023 through this detailed chart. It compares these figures against the national average for all graduates, offering a comprehensive look at the earning potential of Genetics, Bioinformatics & Computational Biology relative to other fields. This data is essential for students assessing the return on investment of their education in Genetics, Bioinformatics & Computational Biology, providing a clear picture of financial prospects post-graduation.

AI in Biotechnology Market size was valued at USD 3.5 Billion in 2024 and is projected to reach USD 19.46 Billion by 2032, growing at a CAGR of 21% during the forecasted period 2026 to 2032.

The AI in Biotechnology Market is driven by the growing need for accelerated drug discovery, precision medicine, and genomic research. AI-powered algorithms enhance data analysis, optimize clinical trials, and improve target identification, reducing time and costs associated with drug development. The rising adoption of machine learning and deep learning in bioinformatics, protein structure prediction, and personalized treatment planning further boosts market growth. Additionally, increasing investments in AI-driven biotech startups, strategic collaborations between tech and pharmaceutical companies, and advancements in computational biology contribute to the market’s expansion. Regulatory support for AI integration in biotech research and the rising demand for automation in laboratory workflows also fuel the adoption of AI in biotechnology.

Trends in biotechnology Acceptance Rate - ResearchHelpDesk - Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences: useful science applied to, derived from, or inspired by living systems. The major themes that TIBTECH is interested in include Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering) Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology) Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics) Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery) Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development) We particularly seek articles that are relevant to more than one of these themes. Additionally, we welcome articles on law and intellectual property, policy and regulation, bioethics, scientific communication, and the economics of biotechnology. Reviews of mechanistic or phenomenological biology are generally not within TIBTECH's scope, although we do consider reviews of technologies developed from basic biology as long as there's an application in mind. TIBTECH has a diverse audience that reflects its intentionally broad scope. Our readers include not only biologists but also engineers, chemists, pharmacologists, computer scientists, and physicians, and they work in academic, clinical, industrial, NGO, and governmental settings. Therefore, we emphasize accessible articles that are easy to read, and we encourage authors to keep in mind that many readers may not be familiar with their field's specific terminology. For more of TIBTECH editor Matt Pavlovich's take on the journal's aims and scope, read his posts at CrossTalk, the Cell Press blog: "What I talk about when I talk about biotechnology" and "A data-driven map of biotechnology."

Journal of Applied Biology and Biotechnology FAQ - ResearchHelpDesk - The Journal of Applied Biology & Biotechnology is a open access, peer-reviewed journal published by Open Science Publishers LLP (registers under section 12(1) of LLP Act 2008). The journal publish on Bi-monthly basis (6 issue per year) and available in both online and print format. Aims & Scope Journal of Applied Biology and Biotechnology is a peer-reviewed, open access journal, dedicated to publication of review articles, original research, short communications on applied researches in following fields of Cell biology, Biology, Developmental biology, Structural biology, Microbiology, Molecular biology, Biochemistry, Biotechnology, Food Science, Medicinal Plants, Ethnobotany, Environmental biology, Marine biology, Viorology, Bioinformatics, Biophysics, Evolutionary biology, Plant Science, Plant pathology, Plant physiology, Plant breeding, Nematology, Agriculture Science and Agronomy. Journal Abstracting and Indexing details Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts, J-Gate, Google Scholar, Indian Science Abstracts, Tropical Diseases Bulletin, Science Central, Index Medicus for South-East Asia Region, Review of Aromatic and Medicinal Plants, ScopeMed, EBSCO, Geneva Foundation for Medical Education and Research, Abstracts on Hygiene and Communicable Diseases, Global Health, Plant Genetic Resources Abstracts, Index Copernicus, Genamics JournalSeek.

The size and share of the market is categorized based on Type (Genomics, Proteomics) and Application (Research Labs and Institutes, Drug Discovery, Bioinformatics, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Scientific advancement is hindered without proper genome annotation because biologists lack a complete understanding of cellular protein functions. In bacterial cells, hypothetical proteins (HPs) are open reading frames with unknown functions. HPs result from either an outdated database or insufficient experimental evidence (i.e., indeterminate annotation). While automated annotation reviews help keep genome annotation up to date, often manual reviews are needed to verify proper annotation. Students can provide the manual review necessary to improve genome annotation. This paper outlines an innovative classroom project that determines if HPs have outdated or indeterminate annotation. The Hypothetical Protein Characterization Project uses multiple well-documented, freely available, web-based, bioinformatics resources that analyze an amino acid sequence to (1) detect sequence similarities to other proteins, (2) identify domains, (3) predict tertiary structure including active site characterization and potential binding ligands, and (4) determine cellular location. Enough evidence can be generated from these analyses to support re-annotation of HPs or prioritize HPs for experimental examinations such as structural determination via X-ray crystallography. Additionally, this paper details several approaches for selecting HPs to characterize using the Hypothetical Protein Characterization Project. These approaches include student- and instructor-directed random selection, selection using differential gene expression from mRNA expression data, and selection based on phylogenetic relations. This paper also provides additional resources to support instructional use of the Hypothetical Protein Characterization Project, such as example assignment instructions with grading rubrics, links to training videos in YouTube, and several step-by-step example projects to demonstrate and interpret the range of achievable results that students might encounter. Educational use of the Hypothetical Protein Characterization Project provides students with an opportunity to learn and apply knowledge of bioinformatic programs to address scientific questions. The project is highly customizable in that HP selection and analysis can be specifically formulated based on the scope and purpose of each student’s investigations. Programs used for HP analysis can be easily adapted to course learning objectives. The project can be used in both online and in-seat instruction for a wide variety of undergraduate and graduate classes as well as undergraduate capstone, honor’s, and experiential learning projects.

Global Bioinformatics Market to hit USD 32.76B by 2029 growing at 15.2% CAGR. Explore trends, drivers, and competition for strategic insights with The Business Research Company.

Biotechnology Market size was valued at USD 1023.92 Billion in 2023 and is projected to reach USD 2590.03 Billion by 2031, growing at a CAGR of 12.3% from 2024 to 2031.

Global Biotechnology Market Drivers

Technological Advancements: Rapid advances in technologies like as gene editing (e.g., CRISPR-Cas9), synthetic biology, and bioinformatics are propelling the biotechnology business. These advancements allow for more accurate and efficient manipulation of genetic material, promoting the development of new medicines, agricultural products, and industrial enzymes. The introduction of high-throughput sequencing and computational techniques is speeding research and development, lowered costs and cutting time-to-market for biotechnology goods. This technical advancement is accelerating progress in customized medicine, regenerative medicines, and bio-based manufacturing.

Increasing Healthcare Needs: The increasing frequency of chronic diseases, aging populations, and the global burden of infectious diseases are all driving a strong need for sophisticated medical treatments. Biotechnology has exciting opportunities for producing targeted medicines, vaccines, and diagnostic tools. The rising prevalence of diseases including cancer, diabetes, and unusual genetic illnesses needs novel treatments, many of which are being produced through biotechnological research.

Government Support and Regulatory Frameworks: Supportive government policies, funding, and favorable regulatory frameworks are key drivers of the biotechnology market. Many governments recognize biotechnology’s potential to address significant health, agricultural, and environmental issues, prompting increased funding in R&D programs. Regulatory organizations are also expediting the approval process for biotech products, fostering innovation while assuring safety and efficacy. Public-private collaborations and funding for biotech firms and research institutes are creating a favorable climate for the growth of the biotechnology sector.

Evolving Consumer Preferences: Consumers are increasingly valuing health, well-being, and sustainability, which is fueling demand for biotech technologies. In the food and agriculture industries, there is a rising preference for genetically modified crops that have superior nutritional value, flavor, and yields. In healthcare, patients want individualized and precision medication alternatives, which biotechnology may give. The trend for natural and eco-friendly products is driving the use of biotechnology in a variety of consumer items, including cosmetics and dietary supplements. This shift in consumer behavior encourages businesses to invest in biotechnology research and product development to suit changing market demands.

USalign.zip - US-align version 20220606 used for the alignment benchmark.

RIPC.zip - 20 reference alignments from the RIPC dataset and corresponding protein PDB files.

fold.zip - 954 SCOPe protein domain structures and their corresponding SCOPe 2.08 fold.

Rfam.zip - PDB files for 508 RNA chains and their Rfam 14.8 famillies.